Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock

JACC: Cardiovascular Interventions

Volumn 2, Issue 2, 2009, Pages 146-152

  Lim, Han S ^a,h   Farouque, Omar ^a,b   Andrianopoulos, Nick ^c   Yan, Bryan P ^d,i   Lim, Chris C S ^e   Brennan, Angela L ^c   Reid, Chris M ^c   Freeman, Melanie ^a   Charter, Kerrie ^a   Black, Alexander ^b,d,f   New, Gishel ^e   Ajani, Andrew E ^b,c,d   Duffy, Stephen J ^g   Clark, David J ^a  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e BOX HILL HOSPITAL   (Australia)

^f GEELONG HOSPITAL   (Australia)

^g ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

acute myocardial infarction; cardiogenic shock; elderly; percutaneous coronary intervention

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; AORTA BALLOON; ARTICLE; AUSTRALIA; BLEEDING; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EARLY INTERVENTION; ELDERLY CARE; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STROKE; SURVIVAL RATE; TREATMENT OUTCOME; AGING; COMPLICATION; CONFIDENCE INTERVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; REGISTER; RISK; SHOCK, CARDIOGENIC; STATISTICAL MODEL; TRANSLUMINAL CORONARY ANGIOPLASTY; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; REGISTRIES; SHOCK, CARDIOGENIC; ANGIOPLASTY, BALLOON, CORONARY; KAPLAN-MEIER ESTIMATE;

EID: 59149084405     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.11.006     Document Type: Article

References (37)

1. Furman M.I., Dauerman H.L., Goldberg R.J., Yarzebski J., Lessard D., and Gore J.M. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 37 (2001) 1571-1580
2. Goldberg R.J., Yarzebski J., Lessard D., and Gore J.M. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 33 (1999) 1533-1539
3. The TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet 358 (2001) 951-957
4. Singh M., White J., Hasdai D., et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock. Insights from the GUSTO-I trial. J Am Coll Cardiol 50 (2007) 1752-1758
5. Hasdai D., Topol E.J., Califf R.M., Berger P.B., and Holmes Jr. D.R. Cardiogenic shock complicating acute coronary syndromes. Lancet 356 (2000) 749-756
6. Klein L.W., Shaw R.E., Krone R.J., et al., American College of Cardiology National Cardiovascular Data Registry. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 96 (2005) 35-41
7. Reynolds H.R., and Hochman J.S. Cardiogenic shock: current concepts and improving outcomes. Circulation 117 (2008) 686-697
8. Fox K.A., Anderson Jr. F.A., Dabbous O.H., et al., GRACE Investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 93 (2007) 177-182
9. Babaev A., Frederick P.D., Pasta D.J., et al., NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 (2005) 448-454
10. Goldberg R.J., Gore J.M., Alpert J.S., et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 325 (1991) 1117-1122
11. Holmes Jr. D.R., Bates E.R., Kleiman N.S., et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 26 (1995) 668-674
12. Goldberg R.J., Samad N.A., Yarzebski J., et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340 (1999) 1162-1168
13. Antoniucci D., Valenti R., Santoro G.M., et al. Systematic direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 31 (1998) 294-300
14. Hibbard M.D., Holmes Jr. D.R., Bailey K.R., et al. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 19 (1992) 639-646
15. Dzavík V., Burton J.R., Kee C., et al. Changing patterns of practice in management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients. Can J Cardiol 14 (1998) 923-930
16. Ajani A.E., Maruff P., Warren R., et al. Impact of early percutaneous coronary intervention on short- and long-term outcomes in patients with cardiogenic shock after acute myocardial infarction. Am J Cardiol 87 (2001) 633-635
17. Hochman J.S., Sleeper L.A., Webb J.G., et al., SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634
18. Gurwitz J.H., Col N.F., and Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268 (1992) 1417-1422
19. Ajani A.E., Szto G., Duffy S.J., et al., Melbourne Interventional Group Investigators. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 15 (2006) 44-47
20. Yan B.P., Ajani A.E., Duffy S.J., et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust 185 (2006) 363-367
21. Lagerqvist B., James S.K., Stenestrand U., et al., SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
22. Webb J.G., Lowe A.M., Sanborn T.A., et al., SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 42 (2003) 1380-1386
23. Dzavik V., Sleeper L.A., Cocke T.P., et al., SHOCK Investigators. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24 (2003) 828-837
24. Migliorini A., Moschi G., Valenti R., et al. Routine percutaneous coronary intervention in elderly patients with cardiogenic shock complicating acute myocardial infarction. Am Heart J 152 (2006) 903-908
25. Antoniucci D., Valenti R., Migliorini A., et al. Comparison of impact of emergency percutaneous revascularization on outcome of patients ≥75 years of age with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 91 (2003) 1458-1461
26. Zeymer U., Vogt A., Zahn R., et al., Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Predictors of in-hospital mortality in 1,333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Eur Heart J 25 (2004) 322-328
27. Prasad A., Lennon R.J., Rihal C.S., Berger P.B., and Holmes Jr. D.R. Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J 147 (2004) 1066-1070
28. Dauerman H.L., Ryan Jr. T.J., Piper W.D., et al. Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock:a multicenter, decade-long experience. J Invasive Cardiol 15 (2003) 380-384
29. Dzavik V., Sleeper L.A., Picard M.H., et al., SHOCK Investigators. Outcome of patients aged ≥75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?. Am Heart J 149 (2005) 1128-1134
30. Dauerman H.L., Goldberg R.J., Malinski M., Yarzebski J., Lessard D., and Gore J.M. Outcomes and early revascularization for patients ≥65 years of age with cardiogenic shock. Am J Cardiol 87 (2001) 844-848
31. French J.K. Which elderly patients with cardiogenic shock should be treated with percutaneous coronary intervention?. Am Heart J 147 (2004) 950-952
32. Hasdai D. Should we aggressively treat elderly patients with cardiogenic shock?. Am Heart J 149 (2005) 962-963
33. Hochman J.S., Sleeper L.A., White H.D., et al., SHOCK Investigators. One-year survival following early revascularization for cardiogenic shock. JAMA 285 (2001) 190-192
34. Hochman J.S., Sleeper L.A., Webb J.G., et al., SHOCK Investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295 (2006) 2511-2515
35. Brodie B.R., Stuckey T.D., Muncy D.B., et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 145 (2003) 708-715
36. Boersma E., Harrington R.A., Moliterno D.J., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 359 (2002) 189-198
37. Chan A.W., Chew D.P., Bhatt D.L., Moliterno D.J., Topol E.J., and Ellis S.G. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 89 (2002) 132-136